Reirradiation for progressive brain metastases

Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and therapeutics 2009-07, Vol.5 (3), p.161
Hauptverfasser: Bahl, Amit, Kumar, Milind, Sharma, D N, Jothy Basu, K S, Jaura, M S, Rath, G K, Julka, P K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 161
container_title Journal of cancer research and therapeutics
container_volume 5
creator Bahl, Amit
Kumar, Milind
Sharma, D N
Jothy Basu, K S
Jaura, M S
Rath, G K
Julka, P K
description Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the primary modality for the treatment of multiple brain metastases, and improves both the quality of life and survival of patient. Unfortunately, more than half of these treated patients eventually progress leading to a therapeutic dilemma. Another course of radiotherapy is a viable but underutilized option. Reirradiation resolves distressing symptoms and has shown to improve survival with minimal late neurotoxicity. Reirradiation has conventionally been done with whole brain radiotherapy, but now studies with stereotactic radiosurgery have also shown promising results. In this review, we focus on reirradiation as a treatment modality in such patients. We performed a literature search in MEDLINE (www.pubmed.org) with key words brain metastases, reirradiation, whole brain radiotherapy, stereotactic radiosurgery, interstial brachytherapy, and brain. The search was limited to the English literature and human subjects.
doi_str_mv 10.4103/0973-1482.57120
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_862874661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A210079586</galeid><sourcerecordid>A210079586</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-20278a1c1f0e786144cc81159fb070aac2cfbc4991b5bf3ebe556241d7812ec73</originalsourceid><addsrcrecordid>eNptkU1LAzEQhoMotlbP3qToebeZbHaTHEvxCwqC6Dlk00lJ6e7WZCv4701tUYSSQGDyvMkMDyHXQHMOtJhQJYoMuGR5KYDREzIEpWTGoZCnZPh7OyAXMa4oLQVj8pwMQEkOZVkNSf6KPgSz8Kb3XTt2XRhvQrcMGKP_xHEdjG_HDfYmpo3xkpw5s454dThH5P3h_m32lM1fHp9n03lmeaX6jFEmpAELjqKQFXBurQQolaupoMZYZl1tuVJQl7UrsMbUDOOwEBIYWlGMyO3-3dTMxxZjr1fdNrTpSy0rJgWvKkjQ3R5amjVq37quD8Y2Plo9ZUCpUKWsEpUdoZbYYjDrrkXnU_kfnx_h01pg4-3RwGQfsKGLMaDTm-AbE740UL2zpHce9M6D_rGUEjeH6bZ1g4s__qCl-AZ_hYla</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>862874661</pqid></control><display><type>article</type><title>Reirradiation for progressive brain metastases</title><source>MEDLINE</source><source>Medknow Open Access Journals</source><source>Bioline International</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Bahl, Amit ; Kumar, Milind ; Sharma, D N ; Jothy Basu, K S ; Jaura, M S ; Rath, G K ; Julka, P K</creator><creatorcontrib>Bahl, Amit ; Kumar, Milind ; Sharma, D N ; Jothy Basu, K S ; Jaura, M S ; Rath, G K ; Julka, P K</creatorcontrib><description>Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the primary modality for the treatment of multiple brain metastases, and improves both the quality of life and survival of patient. Unfortunately, more than half of these treated patients eventually progress leading to a therapeutic dilemma. Another course of radiotherapy is a viable but underutilized option. Reirradiation resolves distressing symptoms and has shown to improve survival with minimal late neurotoxicity. Reirradiation has conventionally been done with whole brain radiotherapy, but now studies with stereotactic radiosurgery have also shown promising results. In this review, we focus on reirradiation as a treatment modality in such patients. We performed a literature search in MEDLINE (www.pubmed.org) with key words brain metastases, reirradiation, whole brain radiotherapy, stereotactic radiosurgery, interstial brachytherapy, and brain. The search was limited to the English literature and human subjects.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/0973-1482.57120</identifier><identifier>PMID: 19841556</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Brachytherapy ; Brain cancer ; Brain Neoplasms - radiotherapy ; Brain Neoplasms - secondary ; Cancer ; Care and treatment ; Chemotherapy ; Cranial Irradiation - methods ; Development and progression ; Health aspects ; Humans ; Medical treatment ; Metastasis ; Quality of Life ; Radiation therapy ; Radiosurgery ; Radiotherapy ; Radiotherapy Dosage ; Radiotherapy, Adjuvant ; Retreatment ; Risk factors ; Survival Analysis ; Treatment Outcome</subject><ispartof>Journal of cancer research and therapeutics, 2009-07, Vol.5 (3), p.161</ispartof><rights>COPYRIGHT 2009 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Jul 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-20278a1c1f0e786144cc81159fb070aac2cfbc4991b5bf3ebe556241d7812ec73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19841556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bahl, Amit</creatorcontrib><creatorcontrib>Kumar, Milind</creatorcontrib><creatorcontrib>Sharma, D N</creatorcontrib><creatorcontrib>Jothy Basu, K S</creatorcontrib><creatorcontrib>Jaura, M S</creatorcontrib><creatorcontrib>Rath, G K</creatorcontrib><creatorcontrib>Julka, P K</creatorcontrib><title>Reirradiation for progressive brain metastases</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the primary modality for the treatment of multiple brain metastases, and improves both the quality of life and survival of patient. Unfortunately, more than half of these treated patients eventually progress leading to a therapeutic dilemma. Another course of radiotherapy is a viable but underutilized option. Reirradiation resolves distressing symptoms and has shown to improve survival with minimal late neurotoxicity. Reirradiation has conventionally been done with whole brain radiotherapy, but now studies with stereotactic radiosurgery have also shown promising results. In this review, we focus on reirradiation as a treatment modality in such patients. We performed a literature search in MEDLINE (www.pubmed.org) with key words brain metastases, reirradiation, whole brain radiotherapy, stereotactic radiosurgery, interstial brachytherapy, and brain. The search was limited to the English literature and human subjects.</description><subject>Brachytherapy</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - radiotherapy</subject><subject>Brain Neoplasms - secondary</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Chemotherapy</subject><subject>Cranial Irradiation - methods</subject><subject>Development and progression</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Medical treatment</subject><subject>Metastasis</subject><subject>Quality of Life</subject><subject>Radiation therapy</subject><subject>Radiosurgery</subject><subject>Radiotherapy</subject><subject>Radiotherapy Dosage</subject><subject>Radiotherapy, Adjuvant</subject><subject>Retreatment</subject><subject>Risk factors</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkU1LAzEQhoMotlbP3qToebeZbHaTHEvxCwqC6Dlk00lJ6e7WZCv4701tUYSSQGDyvMkMDyHXQHMOtJhQJYoMuGR5KYDREzIEpWTGoZCnZPh7OyAXMa4oLQVj8pwMQEkOZVkNSf6KPgSz8Kb3XTt2XRhvQrcMGKP_xHEdjG_HDfYmpo3xkpw5s454dThH5P3h_m32lM1fHp9n03lmeaX6jFEmpAELjqKQFXBurQQolaupoMZYZl1tuVJQl7UrsMbUDOOwEBIYWlGMyO3-3dTMxxZjr1fdNrTpSy0rJgWvKkjQ3R5amjVq37quD8Y2Plo9ZUCpUKWsEpUdoZbYYjDrrkXnU_kfnx_h01pg4-3RwGQfsKGLMaDTm-AbE740UL2zpHce9M6D_rGUEjeH6bZ1g4s__qCl-AZ_hYla</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>Bahl, Amit</creator><creator>Kumar, Milind</creator><creator>Sharma, D N</creator><creator>Jothy Basu, K S</creator><creator>Jaura, M S</creator><creator>Rath, G K</creator><creator>Julka, P K</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20090701</creationdate><title>Reirradiation for progressive brain metastases</title><author>Bahl, Amit ; Kumar, Milind ; Sharma, D N ; Jothy Basu, K S ; Jaura, M S ; Rath, G K ; Julka, P K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-20278a1c1f0e786144cc81159fb070aac2cfbc4991b5bf3ebe556241d7812ec73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Brachytherapy</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - radiotherapy</topic><topic>Brain Neoplasms - secondary</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Chemotherapy</topic><topic>Cranial Irradiation - methods</topic><topic>Development and progression</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Medical treatment</topic><topic>Metastasis</topic><topic>Quality of Life</topic><topic>Radiation therapy</topic><topic>Radiosurgery</topic><topic>Radiotherapy</topic><topic>Radiotherapy Dosage</topic><topic>Radiotherapy, Adjuvant</topic><topic>Retreatment</topic><topic>Risk factors</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bahl, Amit</creatorcontrib><creatorcontrib>Kumar, Milind</creatorcontrib><creatorcontrib>Sharma, D N</creatorcontrib><creatorcontrib>Jothy Basu, K S</creatorcontrib><creatorcontrib>Jaura, M S</creatorcontrib><creatorcontrib>Rath, G K</creatorcontrib><creatorcontrib>Julka, P K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bahl, Amit</au><au>Kumar, Milind</au><au>Sharma, D N</au><au>Jothy Basu, K S</au><au>Jaura, M S</au><au>Rath, G K</au><au>Julka, P K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reirradiation for progressive brain metastases</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2009-07-01</date><risdate>2009</risdate><volume>5</volume><issue>3</issue><spage>161</spage><pages>161-</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the primary modality for the treatment of multiple brain metastases, and improves both the quality of life and survival of patient. Unfortunately, more than half of these treated patients eventually progress leading to a therapeutic dilemma. Another course of radiotherapy is a viable but underutilized option. Reirradiation resolves distressing symptoms and has shown to improve survival with minimal late neurotoxicity. Reirradiation has conventionally been done with whole brain radiotherapy, but now studies with stereotactic radiosurgery have also shown promising results. In this review, we focus on reirradiation as a treatment modality in such patients. We performed a literature search in MEDLINE (www.pubmed.org) with key words brain metastases, reirradiation, whole brain radiotherapy, stereotactic radiosurgery, interstial brachytherapy, and brain. The search was limited to the English literature and human subjects.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>19841556</pmid><doi>10.4103/0973-1482.57120</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0973-1482
ispartof Journal of cancer research and therapeutics, 2009-07, Vol.5 (3), p.161
issn 0973-1482
1998-4138
language eng
recordid cdi_proquest_journals_862874661
source MEDLINE; Medknow Open Access Journals; Bioline International; EZB-FREE-00999 freely available EZB journals
subjects Brachytherapy
Brain cancer
Brain Neoplasms - radiotherapy
Brain Neoplasms - secondary
Cancer
Care and treatment
Chemotherapy
Cranial Irradiation - methods
Development and progression
Health aspects
Humans
Medical treatment
Metastasis
Quality of Life
Radiation therapy
Radiosurgery
Radiotherapy
Radiotherapy Dosage
Radiotherapy, Adjuvant
Retreatment
Risk factors
Survival Analysis
Treatment Outcome
title Reirradiation for progressive brain metastases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A12%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reirradiation%20for%20progressive%20brain%20metastases&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Bahl,%20Amit&rft.date=2009-07-01&rft.volume=5&rft.issue=3&rft.spage=161&rft.pages=161-&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/0973-1482.57120&rft_dat=%3Cgale_proqu%3EA210079586%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=862874661&rft_id=info:pmid/19841556&rft_galeid=A210079586&rfr_iscdi=true